Christopher D Alafi
CIK 1299430 · last filed 2021-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.42M
Companies
2
Total Filings
87
Lifetime Open-Market Net
$39.60M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Intra-Cellular Therapies, Inc. (ITCI) Delisted | Director | 850,548 | $131.87 | $112.16M | $32.97M | 55 | 2021-05-28 |
| STXS | Director | 1,313,441 | $1.84 | $2.42M | $6.64M | 32 | 2013-08-20 |
Recent Filings · Page 7 of 9
87 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-04-03 | STXS | Other (J) | — | $0 | EDGAR |
| 2012-01-05 | STXS | Grant (A) | +17,647 | $0 | EDGAR |
| 2011-09-13 | STXS | Buy (P) | +64,468 | $86.4K | EDGAR |
| 2011-09-12 | STXS | Buy (P) | +35,532 | $47.3K | EDGAR |
| 2011-06-06 | STXS | Buy (P) | +50,000 | $167.5K | EDGAR |
| 2011-05-27 | STXS | Grant (A) | +3,150 | $0 | EDGAR |
| 2010-11-12 | STXS | Other (J) | — | $0 | EDGAR |
| 2010-08-19 | STXS | Buy (P) | +26,000 | $84.5K | EDGAR |
| 2010-05-28 | STXS | Grant (A) | — | $0 | EDGAR |
| 2010-03-04 | STXS | Buy (P) | +50,000 | $241.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.